Information:
Error:
ID
23882
Description
Study part: Demographics Visit 1. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381
Keywords
Versions (1)
- 7/16/17 7/16/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 16, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Demographics Visit 1 Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381
Similar models
Demographics Visit 1
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date of birth
Item
Date of birth :
date
C0421451 (UMLS CUI [1])
CL Item
Male (Male)
CL Item
Female (Female)
CL Item
Black (Black)
CL Item
Arabic/North African (Arabic/North African)
CL Item
White/Caucasian (White/Caucasian)
CL Item
East & South East Asian (East & South East Asian)
CL Item
South Asian (South Asian)
CL Item
Other, please specify (Other, please specify)
Other
Item
If other, please specify
text
C0205394 (UMLS CUI [1])